Eledon Pharma (NASDAQ:ELDN) just reported results for the second quarter of 2024.
- Eledon Pharma reported earnings per share of -$1.06. This was below the analyst estimate for EPS of -30 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
Eledon Pharma (NASDAQ:ELDN) just reported results for the second quarter of 2024.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/eldn-stock-earnings-eledon-pharma-for-q2-of-2024/.
©2025 InvestorPlace Media, LLC